Clal Biotechnology reported ILS14.69M in Current Assets for its fiscal quarter ending in December of 2023.





Current Assets Change Date
aTyr Pharma USD 93.01M 5.52M Sep/2025
Clal Biotechnology ILS 14.69M 1.95M Dec/2023
Compugen USD 88.92M 8.72M Sep/2025
RedHill Biopharma USD 12.56M 644K Jun/2025